Product name:Clavulanic acid
Product description:Clavulanic acid is a beta-lactamase inhibitor (marketed by GlaxoSmithKline, formerly Beecham) combined with penicillin group antibiotics to overcome certain types of antibiotic resistance. It is used to overcome resistance in bacteria that secrete beta-lactamase, which otherwise inactivates most penicillins. In its most common form, the potassium salt potassium clavulanate is combined with amoxicillin (co-amoxiclav, trade names Augmentin, Synulox [veterinary], and others) or ticarcillin.The substance is also under investigation as a NAALADase inhibitor with purported antidepressant and aphrodisiac properties.Clinical trials are underway on XR (Serdaxin") and IR ("RX-10100"